StockData
Medifast Inc logo

Medifast Inc (MED) income statement

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3066% below fair value
$12.20+0.01 (+0.08%)

Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%

Medifast Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
69.2%
Operating margin
-11.6%
Net margin
-13.6%
Return on equity, FY2025
-9.1%

Financial strength

Current ratio
4.82
Debt to equity
–
Debt to assets
–
Cash to current liabilities
139.4%

Valuation

P/E ratio
–
Price to sales
0.46
Price to book
0.76
Dividend yield
0.00%

See a number that looks wrong?